ATI-450

· Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ATI-450, covering 2023-03-29 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]